On August 18, Rocket Lab USA, Inc. declined 5.4% in regular trading, trading at 79.7 USD/share, with turnover of 2.33 billion USD. Despite early session strength that pushed shares as high as 85.55 USD following positive contract news, the stock reversed sharply as multiple headwinds converged.

On the news front, Rocket Lab announced its selection for the U.S. Space Force NITE-STAR program, a $981 million contract ceiling supporting space test and training infrastructure. However, the positive catalyst was quickly overshadowed by the company's newly filed ATM equity distribution agreement allowing sales of up to $1.944 billion in common shares through Deutsche Bank and Wells Fargo, intensifying dilution concerns. The prior $3 billion ATM agreement was terminated after approximately $1.06 billion in stock had already been sold.

Simultaneously, the options market signaled constrained upside expectations, with a notable $1.066 million sell order on 1,300 contracts of December 2026 110-strike calls — a bearish positioning suggesting institutional traders do not expect shares to break meaningfully above current levels in the near term.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)